Prutine Tablet (Talniflumate)

Adult dose

Administer 370 mg of talniflumate orally per dose, 3 times a day. In severe cases, administer 740 mg per dose. Adjust the dose as appropriate according to age and symptoms.

This drug may cause gastrointestinal bleeding in individuals who regularly consume more than three glasses of alcohol daily; therefore, it is essential to consult a doctor or pharmacist before use. This drug can affect the cardiovascular system, increasing the risk of myocardial infarction or stroke; hence, individuals with a history of cardiovascular disease or risk factors should exercise particular caution. It may cause serious gastrointestinal issues such as gastrointestinal bleeding, ulcers, or perforation; therefore, those with a history of gastrointestinal diseases or the elderly should take it with even more care. Individuals with a history of peptic ulcers or allergies to the ingredients of this drug, as well as those who show hypersensitivity to aspirin or other non-steroidal anti-inflammatory drugs, should not take this medication. It is also safer for pregnant women or those who may become pregnant, nursing mothers, and individuals with severe liver, kidney, or heart dysfunctions to avoid this drug. Individuals with mild to moderate liver, kidney, or heart dysfunction should use this drug cautiously, as should the elderly or those on diuretics. While taking this medication, one may experience side effects such as nausea, vomiting, diarrhea, abdominal pain, skin rash, dizziness, among others; thus, it is important to monitor one's condition closely. Regular blood tests and liver and kidney function tests should be conducted when taking this medication long-term, and if any abnormal symptoms appear, one should consult a healthcare professional immediately. It is best not to use this drug in combination with other anti-inflammatory pain relievers, and it may interact with certain medications, so it is essential to disclose any medications being taken. In the late stages of pregnancy, this drug may pose risks to the fetus; therefore, women who are pregnant or planning to become pregnant should avoid using it, and caution is also necessary during breastfeeding. This drug should not be used in children under 12 years of age, and the elderly should take the minimum dosage cautiously and be especially aware of any adverse reactions. This drug should be kept out of reach of children and should not be transferred to other containers.

Gastrointestinal bleeding, serious cardiovascular thrombotic reaction, myocardial infarction, stroke, nausea, vomiting, photosensitivity, asthma attack, systemic lethargy due to hypotension, hypersensitivity shock, diarrhea, abdominal distension, constipation, dyspepsia, ulcerative stomatitis, abdominal pain, hematemesis, colitis, exacerbation of Crohn's disease, hypertension, tachycardia, chest pain, arrhythmia, palpitations, hypotension, congestive heart failure, edema, hypertension, heart failure, bullous reaction, Stevens-Johnson syndrome, Lyell syndrome, rash, urticaria, pruritus, purpura, dizziness, acute renal failure, interstitial nephritis, nephrotic syndrome, fluoroacetate poisoning, abnormal liver function tests, thrombocytopenia, anemia, anaphylactoid reaction, exfoliative dermatitis, mucocutaneous syndrome, toxic epidermal necrolysis, bronchospasm

This drug should be stored in a tightly closed container to prevent air from entering, and it is best to keep it at room temperature between 1°C and 30°C. This way, the medication's efficacy can be maintained, and deterioration can be prevented.

Appearance

Yellow oblong film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle